ARS Pharmaceuticals Inc. (SPRY)
undefined
undefined%
At close: undefined
12.05
1.13%
After-hours Dec 13, 2024, 07:09 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 30.00K 1.32M 5.51M 17.84M - -
Cost of Revenue 73.00K 17.32M 20.27M 14.07M 1.55M 1.42M
Gross Profit -43.00K -16.00M -14.77M 3.77M -1.55M -1.42M
Operating Income -67.52M -35.52M -19.45M -469.00K -24.07M -18.32M
Interest Income - - 800.00K 400.00K 100.00K 43.00K
Pretax Income -54.37M -34.68M -20.24M -1.06M -23.97M -17.58M
Net Income -54.37M -33.99M -20.24M -1.06M -23.97M -17.58M
Selling & General & Admin 47.28M 18.46M 4.69M 4.23M 1.02M 2.10M
Research & Development 20.27M 18.38M 20.27M 14.07M 21.50M 14.80M
Other Expenses - 974.00K -789.00K -596.00K - -
Operating Expenses 67.55M 36.83M 24.96M 18.30M 22.52M 16.90M
Interest Expense - - 106.00K 29.00K - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 67.55M 36.83M 24.96M 18.30M 24.07M 18.32M
Income Tax - -694.00K -230.56K -200.30K - -
Shares Outstanding (Basic) 95.22M 39.96M 28.87M 34.70M 33.07M 33.07M
Shares Outstanding (Diluted) 95.22M 39.96M 28.87M 34.70M 33.07M 33.07M
EPS (Basic) -0.57 -0.85 -0.7 -0.03 -0.72 -0.53
EPS (Diluted) -0.57 -0.85 -0.7 -0.03 -0.72 -0.53
EBITDA -67.45M -35.52M -19.24M -463.00K -22.52M -16.90M
Depreciation & Amortization 73.00K 319.00K 213.00K 1.71M 1.55M 1.42M